120 related articles for article (PubMed ID: 21421544)
1. Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α.
Weylandt KH; Krause LF; Gomolka B; Chiu CY; Bilal S; Nadolny A; Waechter SF; Fischer A; Rothe M; Kang JX
Carcinogenesis; 2011 Jun; 32(6):897-903. PubMed ID: 21421544
[TBL] [Abstract][Full Text] [Related]
2. Elevated tissue status of omega-3 fatty acids protects against age-related telomere attrition in fat-1 transgenic mice.
Ogłuszka M; Chen CY; Poławska E; Starzyński RR; Liput K; Siekierko U; Pareek CS; Pierzchała M; Kang JX
Clin Nutr; 2024 Jun; 43(6):1488-1494. PubMed ID: 38718720
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Omega-3 Polyunsaturated Fatty Acids Reduce the Number and Differentiation of White Adipocyte Progenitors in Mice.
Chen CY; Su CW; Kang JX
Obesity (Silver Spring); 2020 Feb; 28(2):235-240. PubMed ID: 31721479
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice convert carbohydrates to essential fatty acids.
Pai VJ; Wang B; Li X; Wu L; Kang JX
PLoS One; 2014; 9(5):e97637. PubMed ID: 24836606
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
[TBL] [Abstract][Full Text] [Related]
6. Multi-omic analysis in transgenic mice implicates omega-6/omega-3 fatty acid imbalance as a risk factor for chronic disease.
Kaliannan K; Li XY; Wang B; Pan Q; Chen CY; Hao L; Xie S; Kang JX
Commun Biol; 2019; 2():276. PubMed ID: 31372515
[TBL] [Abstract][Full Text] [Related]
7. N-3 polyunsaturated fatty acids attenuates triglyceride and inflammatory factors level in hfat-1 transgenic pigs.
Liu X; Pang D; Yuan T; Li Z; Li Z; Zhang M; Ren W; Ouyang H; Tang X
Lipids Health Dis; 2016 May; 15():89. PubMed ID: 27161005
[TBL] [Abstract][Full Text] [Related]
8. Unexpected omega-3 activities in intracellular lipolysis and macrophage foaming revealed by fluorescence lifetime imaging.
Tang H; Liu Z; Han G; Geng J; Liu B; Zhang R; Zhang Z
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2321255121. PubMed ID: 38564632
[TBL] [Abstract][Full Text] [Related]
9. Transcriptom and miRNA data of PUFA-enriched stimulated murine macrophage and human endothelial cell lines.
Roessler C; Schumann J
Sci Data; 2023 Jun; 10(1):375. PubMed ID: 37301912
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acid derived lipid mediators: a comprehensive update on their application in anti-cancer drug discovery.
Murray M
Expert Opin Drug Discov; 2024 May; 19(5):617-629. PubMed ID: 38595031
[TBL] [Abstract][Full Text] [Related]
11. Generation of cloned transgenic pigs rich in omega-3 fatty acids.
Lai L; Kang JX; Li R; Wang J; Witt WT; Yong HY; Hao Y; Wax DM; Murphy CN; Rieke A; Samuel M; Linville ML; Korte SW; Evans RW; Starzl TE; Prather RS; Dai Y
Nat Biotechnol; 2006 Apr; 24(4):435-6. PubMed ID: 16565727
[TBL] [Abstract][Full Text] [Related]
12. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis.
Chiu CY; Gomolka B; Dierkes C; Huang NR; Schroeder M; Purschke M; Manstein D; Dangi B; Weylandt KH
Inflamm Res; 2012 Sep; 61(9):967-76. PubMed ID: 22618200
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid-loaded nanoparticles: A state-of-the-art of preparation methods, characterization, functionality, and therapeutic applications.
Ali AH; Hachem M; Ahmmed MK
Heliyon; 2024 May; 10(9):e30946. PubMed ID: 38774069
[TBL] [Abstract][Full Text] [Related]
15. Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids.
Rohwer N; Jelleschitz J; Höhn A; Weber D; Kühl AA; Wang C; Ohno RI; Kampschulte N; Pietzner A; Schebb NH; Weylandt KH; Grune T
Redox Biol; 2023 Aug; 64():102803. PubMed ID: 37392516
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy.
Kouroumalis E; Tsomidis I; Voumvouraki A
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189787
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG; Rabehl M; Pietzner A; Rohwer N; Rothe M; Pech M; Sangro B; Sharma R; Verslype C; Basu B; Sengel C; Ricke J; Schebb NH; Weylandt KH; Benckert J
Front Pharmacol; 2023; 14():1124214. PubMed ID: 36937889
[TBL] [Abstract][Full Text] [Related]
18. Iron as a therapeutic target in chronic liver disease.
Kouroumalis E; Tsomidis I; Voumvouraki A
World J Gastroenterol; 2023 Jan; 29(4):616-655. PubMed ID: 36742167
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine Inhibits Lipopolysaccharide-Stimulated TNF-α but Not Oxylipin Induction in n-3/n-6 PUFA-Enriched Cultures of Circumventricular Organs.
Pflieger FJ; Wolf J; Feldotto M; Nockher A; Wenderoth T; Hernandez J; Roth J; Ott D; Rummel C
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955879
[TBL] [Abstract][Full Text] [Related]
20. Lipid alterations in chronic liver disease and liver cancer.
Paul B; Lewinska M; Andersen JB
JHEP Rep; 2022 Jun; 4(6):100479. PubMed ID: 35469167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
